UBS analyst David Dai downgraded Nuvalent (NASDAQ: NUVL) from Buy to Neutral with a price target of $124.00 (from $138.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE